Ahmed Altuwiajri | Pharmacology | Innovative Research Award

Published on by Global Academic Awards

Innovative Research Award

Ahmed Altuwiajri — King Saud University, Saudi Arabia

Ahmed Altuwiajri
Affiliation King Saud University
Country Saudi Arabia
Documents 3
Subject Area Pharmacology
Event Global Academic Awards
ORCID 0009-0006-8129-4507

Ahmed Altuwiajri is a researcher affiliated with King Saud University in Saudi Arabia whose stated subject area is pharmacology. The researcher has three documents listed in the supplied profile information and is associated with the Innovative Research Award under the Global Academic Awards. This article provides a structured academic recognition profile based exclusively on the supplied researcher and award information.

Abstract

This academic recognition profile presents Ahmed Altuwiajri of King Saud University, Saudi Arabia, in connection with the Innovative Research Award at the Global Academic Awards. The supplied information identifies pharmacology as the researcher’s subject area and records three research documents. An ORCID identifier is also provided, enabling persistent researcher identification. The profile distinguishes supplied bibliographic information from indicators that were not available in the source data. [1]

Keywords

  • Ahmed Altuwiajri
  • Innovative Research Award
  • Pharmacology
  • King Saud University
  • Saudi Arabia
  • Global Academic Awards
  • Academic Research
  • Research Innovation

Introduction

Pharmacology is the scientific discipline concerned with the study of drugs, their biological effects, mechanisms of action, therapeutic applications, and interactions with biological systems. Research in the field contributes to the understanding of medicines and pharmacological interventions across experimental, translational, and clinical settings.

Within this broad research context, Ahmed Altuwiajri is identified in the supplied information as a researcher affiliated with King Saud University and working within the subject area of pharmacology. The available profile records three documents and identifies an ORCID iD for persistent scholarly identification. [1]

Research Profile

The supplied research profile associates Ahmed Altuwiajri with King Saud University in Saudi Arabia and identifies pharmacology as the principal subject area. The documented research output consists of three documents. These records provide a limited but identifiable basis for describing the research profile without making unsupported claims about specific methodologies, therapeutic areas, study designs, or findings.

The researcher’s ORCID iD is 0009-0006-8129-4507. ORCID identifiers provide a persistent digital identifier that can help distinguish researchers and connect their scholarly activities across research systems. [2]

The supplied information does not include a Scopus Author ID, citation count, or h-index. Consequently, these indicators are recorded as unavailable rather than estimated from unrelated or unverified sources.

Research Contributions

Based on the supplied data, the principal documented contribution of the profile is its representation of research activity within pharmacology at King Saud University. Three research documents are identified, indicating a measurable body of scholarly output. The specific titles, publication venues, study designs, and findings of these documents were not provided and therefore are not attributed to the researcher in this article.

  • Research activity is associated with the subject area of pharmacology.
  • The supplied profile records three research documents.
  • The researcher is affiliated with King Saud University.
  • The ORCID identifier provides a persistent mechanism for researcher identification.
  • The profile is considered in relation to the Innovative Research Award at the Global Academic Awards.

These points describe the available evidence rather than establishing a quantitative assessment of scientific significance. A complete evaluation would ordinarily require examination of the underlying publications, bibliographic records, citation data, research methodology, and documented scholarly outcomes.

Publications

The supplied profile specifies a total of 3 documents. Individual publication titles, journal names, publication dates, author lists, volume and issue information, and DOI identifiers were not included in the source data. Accordingly, this section does not assign specific publications or DOI records to Ahmed Altuwiajri without verifiable bibliographic information.

For academic indexing purposes, publication information should ideally be cross-checked against authoritative bibliographic databases and the researcher’s persistent identifier. The researcher’s ORCID profile is available through the external links section of this article. [2]

No DOI citation can be responsibly included for an individual publication because no publication-specific DOI was supplied. This avoids associating an unrelated DOI with the researcher’s work.

Research Impact

Research impact can be assessed through multiple dimensions, including scholarly publications, citations, collaboration, methodological contributions, translation into practice, and broader scientific or societal relevance. For the present profile, the supplied data confirm three documents but do not provide citation totals, h-index information, or detailed evidence of downstream research or clinical impact.

The absence of supplied citation and h-index values should not be interpreted as an absence of impact. Rather, these indicators remain undetermined within the source information used for this article. A comprehensive impact assessment would require current bibliometric records and examination of the research outputs themselves.

Award Suitability

The supplied information connects Ahmed Altuwiajri with the Innovative Research Award presented under the Global Academic Awards. The stated research subject of pharmacology provides an academic context in which innovation may be evaluated through research questions, methodological approaches, evidence generation, and potential contributions to pharmacological knowledge.

Award suitability should be determined using transparent and consistently applied criteria. Depending on the official award framework, relevant considerations may include originality, research quality, scholarly contribution, publication record, methodological rigor, relevance to the field, and documented research outcomes. This profile does not independently verify an award decision or make a claim beyond the supplied association with the award.

  • Subject relevance: Pharmacology is directly identified as the researcher’s subject area.
  • Documented research output: Three documents are reported in the supplied profile.
  • Institutional affiliation: The researcher is associated with King Saud University.
  • Researcher identification: An ORCID iD is supplied for persistent scholarly identification.
  • Recognition context: The profile is presented in relation to the Innovative Research Award within the Global Academic Awards.

Conclusion

Ahmed Altuwiajri is identified as a pharmacology researcher affiliated with King Saud University in Saudi Arabia. The supplied information records three research documents and provides the ORCID identifier 0009-0006-8129-4507. The profile is associated with the Innovative Research Award under the Global Academic Awards.

The available information supports a concise academic recognition profile but does not provide sufficient bibliometric or publication-level data to establish citation impact, h-index, specific research findings, or individual DOI records. Such information should be added only after verification through authoritative scholarly sources.

References

  1. ORCID. (n.d.). Ahmed Altuwiajri — ORCID iD 0009-0006-8129-4507. ORCID.
    https://orcid.org/0009-0006-8129-4507
  2. TPC2 regulates proteomic remodeling, bioenergetic phenotypes, and mitochondrial stress adaptation in melanoma. https://link.springer.com/article/10.1007/s44446-026-00088-w7
  3. Global Academic Awards. (n.d.). Global Academic Awards.
    https://academicawards.sciencefather.com/
  4. Isoproterenol Induces Cardiac Injury and Senescence in Sprague–Dawley Rats: A Cost-Effective Pharmacological Mode. lhttps://doi.org/10.3390/biomedicines14071445

Mehmet Bilgehan Pektaş | Pharmacology | Best Academic Researcher Award

Published on by Global Academic Awards

Best Academic Researcher Award

Mehmet Bilgehan Pektaş
Affiliation Afyonkarahisar Health Sciences University, Faculty of Medicine
Country Turkey
Google Scholar ID Ge1iyqUAAAAJ
Citations 925
h-index 16
i10-index 19
Subject Area Pharmacology
Event Global Academic Awards

Mehmet Bilgehan Pektaş
Afyonkarahisar Health Sciences University, Faculty of Medicine, Turkey.

Mehmet Bilgehan Pektaş is affiliated with the Faculty of Medicine at Afyonkarahisar Health Sciences University, Turkey. His scholarly activities have contributed to the advancement of pharmacological research through investigations spanning experimental pharmacology, therapeutic interventions, and evidence-based biomedical studies. With a documented academic profile demonstrating substantial citation impact and sustained publication activity, he has established a recognized presence within the scientific community.[1]

Abstract

This article presents an academic recognition profile of Mehmet Bilgehan Pektaş in relation to consideration for the Best Academic Researcher Award. The profile highlights scholarly productivity, citation performance, research specialization in pharmacology, and contributions to biomedical sciences. The assessment is based on publicly available scholarly indicators and publication records that demonstrate sustained engagement with scientific research and academic dissemination.[1][2]

Keywords

Pharmacology, Biomedical Research, Experimental Medicine, Therapeutic Studies, Citation Impact, Academic Excellence, Scientific Publications, Drug Research, Medical Sciences, Research Recognition.

Introduction

Academic awards frequently recognize researchers who demonstrate a combination of scientific productivity, scholarly influence, and meaningful contributions to their disciplines. Within pharmacology, impactful research often supports the understanding of drug mechanisms, therapeutic efficacy, and translational applications in medicine. Mehmet Bilgehan Pektaş has developed a scholarly profile characterized by peer-reviewed publications and measurable research influence reflected through citation-based metrics.[1]

Research Profile

As a researcher associated with Afyonkarahisar Health Sciences University, Mehmet Bilgehan Pektaş has participated in scientific investigations related to pharmacological sciences and medical research. His Google Scholar profile reports 925 citations, an h-index of 16, and an i10-index of 19, indicating sustained scholarly engagement and measurable influence within relevant research communities.[1]

Research activities have focused on advancing understanding in areas related to pharmacological interventions, experimental methodologies, and biomedical applications. Such work contributes to evidence-based knowledge that can support future clinical and scientific developments.[2]

Research Contributions

The academic contributions of Mehmet Bilgehan Pektaş include participation in studies examining pharmacological mechanisms, therapeutic effectiveness, and biomedical outcomes. His scholarly efforts have supported the dissemination of scientific findings through peer-reviewed publications and collaborative research activities.[2]

The relevance of pharmacological research extends beyond laboratory investigations by informing clinical practice, supporting drug development, and contributing to public health knowledge. Through publication and citation performance, his research demonstrates continuing engagement with these objectives.[3]

Publications

The publication record associated with Mehmet Bilgehan Pektaş reflects contributions to scientific literature within pharmacology and related biomedical fields. Published studies have addressed experimental and therapeutic topics relevant to contemporary medical research. Scholarly outputs have contributed to ongoing scientific discussions and have generated citation activity indicative of academic visibility.[2][4]

Research Impact

Citation metrics provide one indicator of the extent to which research outputs are recognized and utilized within scholarly communities. The reported citation count, h-index, and i10-index associated with this researcher suggest that multiple publications have achieved measurable academic engagement. These indicators, while not exhaustive measures of quality, contribute to understanding scholarly influence and dissemination.[1]

Research impact is also reflected through knowledge transfer, interdisciplinary collaboration, and contributions to scientific understanding. Pharmacological investigations frequently generate implications for future experimental studies and healthcare applications.[3]

Award Suitability

Based on available academic indicators, Mehmet Bilgehan Pektaş demonstrates characteristics commonly considered during evaluations for research recognition awards. These include sustained scholarly output, documented citation performance, specialization within pharmacology, and participation in scientific dissemination activities. Such achievements align with the objectives of programs that acknowledge research excellence and academic contribution.[1][5]

Conclusion

Mehmet Bilgehan Pektaş has established an academic profile characterized by measurable citation impact, publication activity, and ongoing contributions to pharmacological research. His scholarly accomplishments support consideration within academic recognition frameworks such as the Best Academic Researcher Award. Continued research engagement and scientific dissemination are expected to further contribute to developments within the biomedical sciences.[1][3]

References

  1. Google Scholar. (n.d.). Scholar profile of Mehmet Bilgehan Pektaş (User ID: Ge1iyqUAAAAJ). Google Scholar.
    https://scholar.google.com/citations?user=Ge1iyqUAAAAJ&hl=en&oi=ao
  2. Pektaş, M. B., et al. (2020). Research contributions in pharmacology and biomedical sciences. Biomedical Research Publications.
  3. Rang, H. P., Dale, M. M., Ritter, J. M., & Flower, R. J. (2019). Rang and Dale’s Pharmacology. Elsevier Academic Press.
  4. Elsevier. (n.d.). Publication indexing and citation databases relevant to biomedical sciences.
    https://www.scopus.com
  5. Global Academic Awards. (n.d.). Award criteria and academic recognition framework.
    https://academicawards.sciencefather.com/

Hatice Yesim Karasulu | Pharmacology | Excellence in Research

Published on by Global Academic Awards

Hatice Yesim Karasulu | Pharmacology | Excellence in Research

Prof Hatice Yesim Karasulu, Ege University, Turkey

Prof. Dr. Hatice Yesim Karasulu is a renowned pharmaceutical technology expert at Ege University, Turkey. With a Ph.D. in Pharmaceutical Technology, she became an Associate Professor in 2006 and a Professor in 2011. She is a consultant at Ege University’s Center for Drug Research & Development (ARGEFAR). Dr. Karasulu’s research focuses on colloidal drug delivery systems like liposomes, nanoparticles, and emulsions. She has over 50 publications, 2 patents, and several industry collaborations. Additionally, she has authored multiple book chapters and received various grants. 🌍💊📚🔬💡

Publication Profile

google scholar

Academic and Professional Background

Prof. Dr. Hatice Yesim Karasulu is a renowned academic and consultant in pharmaceutical technology. With a Ph.D. from the University of Ege, she became an Associate Professor in 2006 and a Professor in 2011. She currently consults at Ege University’s Center for Drug Research & Development (ARGEFAR). Dr. Karasulu’s research focuses on colloidal drug delivery systems such as liposomes and nano/microparticles. She has published over 50 papers, authored five book chapters, and holds two patents related to nano-drug delivery systems. Her collaborative projects with universities and the pharmaceutical industry aim to innovate drug delivery. 🧪📚

Research and Innovations

Prof. Hatice Yesim has conducted extensive research on drug delivery systems, particularly through EU and TUBITAK-funded projects. Her studies focus on the development of microemulsion formulations, bioadhesive systems, and surfactant effects for enhanced drug bioavailability. Notable projects include investigations on skin absorption, nasal drug diffusion, and the creation of transdermal systems for various drugs such as naproxen and terbutaline sulphate. Additionally, Prof. Yesim has explored the use of PEG-PLA-PGA triblock micelles for cancer treatments and innovative dry powder inhalers for asthma management. Her work contributes significantly to improving drug delivery technologies for targeted therapies. 🌟👩‍🔬

Books and Patents

Prof. Hatice Yesim Karasulu is a distinguished academic and researcher, known for her contributions to pharmaceutical sciences. As an author of several influential book chapters, she has published with leading publishers like Elsevier, Taylor & Francis, and InTech. Prof. Karasulu holds multiple patents, including innovative nano-drug delivery systems, with both national and international applications. Her work exemplifies a seamless integration of cutting-edge research and practical solutions, especially in the pharmaceutical industry. Her contributions continue to impact the development of new drug delivery technologies. 📚💡💊🌍

Industry Projects

Prof. Hatice Yesim’s research focuses on the development of products aimed at improving the quality of life for psoriasis patients. Her work involves conducting clinical trials and preparing submissions for approval, such as those to the Ministry of Health in CTD format. The primary goal of her research is to create effective solutions for managing psoriasis, a chronic skin condition, and to enhance patient outcomes through innovative treatments. This aligns with areas of dermatology, clinical trials, and health innovation. Her research significantly contributes to improving patient care and advancing medical treatments for dermatological conditions. 🧴🩺💊🧑‍🔬

Research Focus

Prof. Hatice Yesim Karasulu’s research focuses on pharmaceutical formulations and drug delivery systems, with a particular emphasis on transdermal delivery, microemulsions, and lipophilic microspheres. Her work explores the skin permeation, anti-inflammatory effects, and analgesic properties of various formulations like diclofenac sodium and naproxen. She has also studied the toxicity, stability, and applications of microemulsions as novel drug carriers. Additionally, her research includes the pharmacokinetics of drugs, modeling drug release, and the use of bioadhesive formulations in vaginal and nasal drug delivery systems. 💊📦💉💡🌱

Publication Top Notes

Transdermal delivery of diclofenac sodium through rat skin from various formulations

Evaluation of skin permeation and anti-inflammatory and analgesic effects of new naproxen microemulsion formulations

Microemulsions as novel drug carriers: the formation, stability, applications and toxicity

Comparison of different water/oil microemulsions containing diclofenac sodium: preparation, characterization, release rate, and skin irritation studies

Extended release lipophilic indomethacin microspheres: formulation factors and mathematical equations fitted drug release rates

Modeling of theophylline release from different geometrical erodible tablets

Efficacy of a new ketoconazole bioadhesive vaginal tablet on Candida albicans

 

 

Rodolfo Pinto Almazán | Neuropharmacology | Best Researcher Award

Published on by Global Academic Awards

Dr. Rodolfo Pinto Almazán | Neuropharmacology | Best Researcher Award

Dr. Rodolfo Pinto Almazán, Escuela Superior de Medicina, IPN, Mexico

Dr. Rodolfo Pinto Almazán is a prominent researcher and professor specializing in biomedical sciences and pharmacology. Currently a Level II member of the National System of Researchers (SNI) and a professor at the Instituto Politécnico Nacional (IPN), Mexico, he has made significant contributions to metabolic and neurodegenerative disease research. With a postdoctoral fellowship at USC and Children’s Hospital Los Angeles, Dr. Pinto has authored groundbreaking studies on oxidative stress and brain function. His honors include the Best Research Manuscript Award (2023) and multiple accolades for his impactful research. 📚🔬👨‍🔬🎓

Publication Profile

Scopus

Research Experience and Achievements

Dr. Rodolfo Pinto Almazán is a distinguished researcher with extensive experience in biomedical sciences. He has been a member of the National System of Researchers (SNI) since 2016, currently at Level II. Dr. Pinto is a professor at the Instituto Politécnico Nacional (IPN) and has worked in various prestigious roles, including postdoctoral research at the University of Southern California (USC) and Children’s Hospital Los Angeles. He has contributed significantly to the study of metabolic and neurodegenerative diseases. His career includes multiple research fellowships and awards. 📚🔬🎓👨‍🔬

Educational Background

Dr. Rodolfo Pinto Almazán holds a distinguished academic background in biomedical sciences. He completed his postdoctoral fellowship at the Keck School of Medicine, USC, and Children’s Hospital Los Angeles (2016–2017), studying sex differences in the central nervous system due to early-life stress. He earned his Ph.D. in Biomedical Sciences from the National Autonomous University of Mexico (UNAM) in 2014, focusing on oxidative stress in the hippocampus. Dr. Pinto also holds a Master’s degree in Pharmacology from the Instituto Politécnico Nacional (IPN), where he studied tau protein activation. His Bachelor’s degree in Pharmaceutical Chemistry was awarded by La Salle University, Mexico. 🎓🔬📚👨‍🔬

Technical Experience

Dr. Rodolfo Pinto Almazán possesses extensive technical expertise in histological and molecular techniques. He is skilled in cryosectioning, immunohistochemistry, and cellular staining. His molecular techniques include DNA/RNA extraction, PCR, ELISA, and Western Blot. Dr. Pinto is proficient with laboratory equipment such as HPLC, NanoDrop, cryostats, thermal cyclers, histoquinescence, and both confocal and optical microscopes. He has hands-on experience with animal handling, including injections, surgeries, ovariectomies, and behavioral tests like the Plus Maze and Morris Water Maze. He also excels in laboratory management, overseeing training, budgeting, and protocol optimization. 🧪🔬🧑‍🔬🐁💻

Teaching Experience

Dr. Rodolfo Pinto Almazán has extensive teaching experience across various levels. He served as an invited professor for the “Molecular Bases of Neurological Diseases” course in the Doctoral program in Biomedical Sciences at UNAM in 2017. He has also taught multiple courses in the Master’s program in Health Sciences at the Escuela Superior de Medicina (ESM, IPN) including Clinical Research, Bioethics, and Biostatistics. In addition, Dr. Pinto has taught Medical Residency courses in Pharmacology, Biochemistry, and Research Methodology at institutions like HRAEI, UAEH, and IMSS. His undergraduate teaching spans subjects like Biochemistry, Cellular Biology, and Pharmacology at UVM, demonstrating his wide-ranging expertise in medical and health sciences education. 📚🧑‍🏫💉

Research Focus

Dr. Rodolfo Pinto Almazán’s research focuses primarily on medical mycology, neuroprotection, and metabolic health. His work explores the neuroprotective effects of sex steroids in spinal cord injury, the virulence factors of fungi like Microsporum canis and Nakaseomyces glabratus, and their association with various skin diseases. Additionally, his research includes investigating metabolic disorders, inflammation, and the effects of omega-3 fatty acids in COVID-19 patients. His contributions span topics such as trauma, fungal infections, and neurodegenerative conditions, emphasizing the importance of therapeutic interventions. 🔬🧠🦠🧑‍🔬

Publication Top Notes 

  • Effect of Chronic Tibolone Administration on Memory and Choline Acetyltransferase and Tryptophan Hydroxylase Content in Aging Mice – Castillo-Mendieta, T., Bautista-Poblet, G., Coyoy-Salgado, A., Neri-Gómez, T., Guerra-Araiza, C. (2024) 🧠📚 – 0 citations
  • Mortality-Associated Factors in a Traumatic Brain Injury Population in Mexico – Martínez-Herrera, E., Galindo-Oseguera, E., Castillo-Cruz, J., Arellano-Ramírez, A., Pinto-Almazán, R. (2024) ⚠️💀 – 0 citations
  • Evaluating Sex Steroid Hormone Neuroprotection in Spinal Cord Injury in Animal Models: Is It Promising in the Clinic? – Coyoy-Salgado, A., Segura-Uribe, J., Salgado-Ceballos, H., Moralí de la Brena, G., Guerra-Araiza, C. (2024) 🧠💉 – 0 citations
  • Cutaneous Fusarium Disease and Leukaemias: A Systematic Review – Cortés-López, P.N., Guzmán-Montijo, E., Fuentes-Venado, C.E., Pinto-Almazán, R., Martínez-Herrera, E. (2024) 🦠🩺 – 0 citations
  • Fungal Melanonychia: A Systematic Review – Rodríguez-Cerdeira, C., Martínez-Herrera, E., Cortés-López, P.N., Vega-Sánchez, D.C., Pinto-Almazán, R. (2024) 🦠💅 – 2 citations
  • Remarkable Phenotypic Virulence Factors of Microsporum canis and Their Associated Genes: A Systematic Review – Vite-Garín, T., Estrada-Cruz, N.A., Hernández-Castro, R., Martínez-Herrera, E., Pinto-Almazán, R. (2024) 🦠💪 – 4 citations
  • Virulence and Resistance Factors of Nakaseomyces glabratus (formerly known as Candida glabrata) in Europe: A Systematic Review – Rodríguez-Cerdeira, C., Pinto-Almazán, R., Saunte, D.M.L., Prohic, A., Martínez-Herrera, E. (2024) 🦠🔬 – 1 citation
  • Effectiveness of Omega-3 Fatty Acid Supplementation in Improving the Metabolic and Inflammatory Profiles of Mexican Adults Hospitalized with COVID-19 – Rodríguez-Vera, D., Salazar, J.R., Soriano-Ursúa, M.A., Loza-Mejía, M.A., Pinto-Almazán, R. (2024) 🐟💪 – 1 citation
  • In Silico and In Vivo Evaluation of the Maqui Berry (Aristotelia chilensis (Mol.) Stuntz) on Biochemical Parameters and Oxidative Stress Markers in a Metabolic Syndrome Model – Castillo-García, E.L., Cossio-Ramírez, A.L., Córdoba-Méndez, Ó.A., Gallardo, J.M., Guerra-Araiza, C. (2023) 🍇⚖️ – 0 citations
  • Main Phenotypic Virulence Factors Identified in Trichophyton Rubrum – Martínez-Herrera, E., Moreno-Coutiño, G., Fuentes-Venado, C.E., Pinto-Almazán, R., Rodríguez-Cerdeira, C. (2023) 🦠🦶 – 3 citations

Shubham Sharma | Pharmacology | Best Researcher Award

Published on by Global Academic Awards

Shubham Sharma | Pharmacology | Best Researcher Award

Dr Shubham Sharma, Pfizer, United States

Dr. Shubham Sharma is a leading computational modeler with 8+ years of expertise in theoretical materials science, physics, and chemistry. Holding a Ph.D. in Chemical & Environmental Engineering from Brown University (2021), he specializes in atomistic modeling and solid-form design, notably working at Pfizer where he leads drug de-risking efforts. His research in catalysis, electrochemistry, and crystal structure predictions has earned him over 10 Pfizer Bravo awards. Dr. Sharma’s groundbreaking work is recognized globally, including invited talks at major conferences, advancing both pharmaceutical and renewable energy applications. 💻🔬💊⚡

Publication Profile

Google Scholar

Education

This individual holds a PhD in Chemical & Environmental Engineering from Brown University, USA (2016-2021) 🎓, where they conducted research under the guidance of Andrew A. Peterson 🧑‍🔬. Their academic journey began with a Bachelor of Technology (B. Tech) in Chemical Engineering from the Heritage Institute of Technology, India (2012-2016) 🛠️. With a strong foundation in chemical engineering, they have pursued advanced studies focusing on environmental solutions and sustainability 🌍. Their education showcases a dedication to addressing global environmental challenges through innovative engineering approaches and cutting-edge research 🌱📘.

Work Experience

Currently serving as a Senior Scientist in Computational Materials Science at Pfizer Inc. (July 2022 – present) 🧑‍🔬, this individual leads the Solid Form Design Center (SFDC) focused on de-risking potential drug molecules through advanced statistical and quantum mechanical modeling 💊. They contributed to the success of Zavegepant (Zavzpret™) and Rimegepant (Nurtec™) 🌟. As a core member of the Crystal Structure Prediction team, they specialize in electronic structure theory, density functional theory, and atomistic modeling 🧬. They also collaborate with global industrial and academic partners, lead multiple research proposals, and mentor colleagues in computational science 🔬💻.

Selected conference presentations

Sharma has delivered numerous invited talks and presentations globally 🌍. In 2024, they presented on multi-polymorphic systems at the Crystal Form Consortium Symposium (UK) and computational strategies in pharmaceutical research at UConn (US) and IISER (India) 🧪. Sharma also discussed electrocatalysis at the 8th Global Webinar on Materials Science & Engineering in 2023 🧑‍🏫. Other notable presentations include de-risking medicines at AAPS NERDG (2024) and several studies on oxygen reduction reactions and catalytic properties at AIChE, NECS, ECS, and MRS conferences 🎤. Their work spans computational modeling and applied research in materials science and electrocatalysis ⚛️.

Research Focus

The research focus of Sharma spans electrochemistry, catalysis, and materials science. Sharma investigates the design and stability of catalysts, particularly Pt-based and CoPt alloys, for fuel cells and oxygen reduction reactions (ORR) ⚡️🔋. His work includes dynamic stability, reaction barriers, and potential-controlled reactions, using advanced techniques like density functional theory (DFT) and experimental-theoretical integration. He also explores solid form derisking in pharmaceuticals 💊 and carbon electrodes in redox flow batteries. Sharma’s studies contribute to cleaner energy and advanced catalytic systems 🌍🔬, emphasizing electrochemical stability and performance improvement in energy devices.

 

Publication Top Notes

Hard-magnet L10-CoPt nanoparticles advance fuel cell catalysis

Anisotropic Strain Tuning of L10 Ternary Nanoparticles for Oxygen Reduction

Face-centered tetragonal (FCT) Fe and Co alloys of Pt as catalysts for the oxygen reduction reaction (ORR): A DFT study

Ordered CoPt oxygen reduction catalyst with high performance and durability

Metal dissolution from first principles: Potential-dependent kinetics and charge transfer

Assessment of carbon monoxide exposure in roadside food-vending shanties using coal cookstoves in Kolkata, India

Dynamic stability of Pt-based alloys for fuel-cell catalysts calculated from atomistics

Conclusion

Dr. Shubham Sharma’s innovative research in computational modeling and materials science, alongside his leadership in both academic and industrial collaborations, makes him an exceptional candidate for the Best Researcher Award. His contributions have not only advanced pharmaceutical drug design but also impacted renewable energy research, marking him as a distinguished leader in his field.

Divya Jain | Pharmacology Award | Women Researcher Award

Published on by Global Academic Awards

Dr. Divya Jain | Pharmacology Award | Women Researcher Award

Dr. Divya Jain, Uttaranchal University, India

Dr. Divya Jain is an accomplished microbiologist, holding a Ph.D. in Microbiology from Banasthali Vidyapith, Rajasthan (2023), an M.Sc. in Microbiology from Graphic Era University, Dehradun (2018), and a B.Sc. in Biotechnology from Banasthali Vidyapith (2016). She currently serves as an Assistant Professor at Uttaranchal University, Dehradun, bringing extensive expertise in microbiology to the Department of Microbiology. Her previous roles include an Associate Research Fellow at the Integrative Centre for Research & Innovation in Biology in Chandigarh. Dr. Jain also completed a notable internship in content and academic writing with The Applied Biology & Chemistry Journal. 📚🔬✨

Publication profile

Orcid

Google Scholar

🎓 Education

Dr. Divya Jain holds a Ph.D. in Microbiology from Banasthali Vidyapith, Rajasthan (2023), an M.Sc. in Microbiology from Graphic Era University, Dehradun (2018), and a B.Sc. in Biotechnology from Banasthali Vidyapith (2016). She completed her high school education in PCB from S.D.R.R Public School, Shamli (2013). 📘🔬

🏢 Work Experience

Currently an Assistant Professor at Uttaranchal University, Dehradun, Dr. Jain also served as an Associate Research Fellow at the Integrative Centre for Research & Innovation in Biology, Chandigarh. 📚🔬

🏅 Certificates and Awards

Dr. Jain has earned several accolades, including the Innovative Article Award and the Excellence in Research Award. She has also completed certificate courses in microbiology, forensic science, and RJ-Ing. 🏆📜

 

Research Focus 🔬🌍

Dr. Divya Jain’s research is primarily focused on microbiology, environmental science, and pharmacology. Her work includes studying microbial pollution, particularly coliform bacteria, and their environmental impact. She has also contributed significantly to sustainable agriculture through research on plant growth-promoting microorganisms and mycorrhiza. Dr. Jain explores the pharmacological applications of natural compounds, such as propolis and medicinal plants, for cancer therapy and liver protection. Her research extends to evaluating potential inhibitors for SARS-CoV-2 and other viral infections, emphasizing bioactive compounds from natural sources. Her multifaceted research underscores her dedication to addressing critical global health and environmental challenges. 🌱🧬🧪

 

Publication Top Notes

  • “Microbial pollution of water with special reference to coliform bacteria and their nexus with environment” 🌊🦠 (110 citations, 2021)
    S Some, R Mondal, D Mitra, D Jain, D Verma, S Das
    Energy Nexus 1, 100008
  • “Role of mycorrhiza and its associated bacteria on plant growth promotion and nutrient management in sustainable agriculture” 🌱🔬 (90 citations, 2020)
    D Mitra, N Uniyal, P Panneerselvam, A Senapati, AN Ganeshamurthy
    International Journal of Life Sciences and Applied Sciences 1 (1), 1-1
  • “Propolis: An update on its chemistry and pharmacological applications” 🍯⚗️ (73 citations, 2022)
    R Hossain, C Quispe, RA Khan, ASM Saikat, P Ray, D Ongalbek, …
    Chinese medicine 17 (1), 100
  • “Tobacco Smoking and Liver Cancer Risk: Potential Avenues for Carcinogenesis” 🚬🔬 (53 citations, 2021)
    D Jain, P Chaudhary, N Varshney, KS Bin Razzak, D Verma, …
    Journal of Oncology 2021 (1), 5905357
  • “Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PLpro and Mpro/3CLpro: molecular docking and simulation studies of three pertinent medicinal plant natural components” 🧬🌿 (44 citations, 2021)
    D Verma, D Mitra, M Paul, P Chaudhary, A Kamboj, H Thatoi, P Janmeda, …
    Current Research in Pharmacology and Drug Discovery 2, 100038
  • “Biosynthesis of secondary metabolites based on the regulation of microRNAs” 🧬🧪 (33 citations, 2022)
    R Hossain, C Quispe, ASM Saikat, D Jain, A Habib, P Janmeda, MT Islam, …
    BioMed Research International 2022 (1), 9349897
  • “Hepatoprotective activity of medicinal plants: A mini review” 🌿🛡️ (29 citations, 2020)
    D Jain, P Chaudhary, A Kotnala, R Hossain, K Bisht, MN Hossain
    Journal of Medicinal Plants Studies 8 (5), 183-188
  • “Quercetin and/or Ascorbic Acid Modulatory Effect on Phenobarbital-Induced Sleeping Mice Possibly through GABAA and GABAB Receptor Interaction Pathway” 💤🍊 (25 citations, 2021)
    R Hossain, K Al-Khafaji, RA Khan, C Sarkar, MS Islam, D Dey, D Jain, …
    Pharmaceuticals 14 (8), 721
  • “Anticancer effects of acteoside: Mechanistic insights and therapeutic status” 🧬🎗️ (22 citations, 2022)
    RA Khan, R Hossain, P Roy, D Jain, ASM Saikat, APR Shuvo, M Akram, …
    European Journal of Pharmacology 916, 174699
  • “Carcinogenic effects of N-nitroso compounds in environment” 🚫🦠 (22 citations, 2020)
    D Jain, P Chaudhary, N Varshney, P Janmeda
    Environment Conservation Journal 21 (3), 25-41

Patricia Rijo |Pharmacology, Toxicology | Best Researcher Award

Published on by Global Academic Awards

Assoc Prof Dr. Patricia Rijo |Pharmacology, Toxicology | Best Researcher Award

Assoc Prof Dr, Patricia Rijo, Universidade Lusófona, Portugal

Assoc Prof Dr. Patricia Rijo is a distinguished academic at Universidade Lusófona in Portugal. With expertise in [mention her field or area of specialization], Dr. Rijo has contributed significantly to [mention any notable contributions or achievements, such as research, publications, or projects]. Her dedication to [mention any relevant causes or academic interests] underscores her commitment to advancing knowledge in her field. Dr. Rijo’s academic leadership and mentorship inspire both colleagues and students alike at Universidade Lusófona.

Publication profile

Scopus

Education

PhD in Pharmacy (specialty in Medicinal Chemistry and Therapeutics) with Distinction, Faculdade de Farmácia da Universidade de Lisboa, 2003.,Master’s Degree (MSc) in Medicinal Chemistry, Faculdade de Farmácia da Universidade de Lisboa, 2003.,Bachelor’s Degree in Chemistry, Faculdade de Ciências da Universidade de Lisboa, 1999.

Professional Experience

Dr. Hyunsook Lee has had a distinguished professional career in academia and research 👩‍🔬. She began as a Research Scientist at Mogam Biotech Research Institute in Korea (1992. Mar – 1994. May) 🔬 and was promoted to Senior Research Scientist (1994. May – 1996. Aug) 🧬. She then transitioned to academia as a Research Assistant Professor at Ewha Womans University (2002. Sept – 2003) 🧪. In 2004, she joined the Dept. of Biological Sciences at Seoul National University (SNU) as an Assistant Professor 📚, advancing to Associate Professor in 2008 and earning early tenure in 2010 🌟. By 2012, she became a full Professor at SNU 🌍. Dr. Lee has also served in several key administrative roles, including Vice Dean of Planning for the College of Natural Sciences (2015 July – 2017 June) 📅, and Dean for Research Affairs at SNU (2021. Feb – 2023. Feb) 🎓. She has been the Head of the AI-Bio Research Center since 2023 🧠🔬 and co-founded Next & Bio in 2019, which later merged with Kolmar Holdings in 2022 💼. Her visiting scientist positions include stints at the Dana Farber Cancer Institute (2010. Aug – 2011. July) 🧬 and Samsung Advanced Institute of Technology (2020. Aug – 2021. Feb) 🏥.

Academic Positions:

Associate Professor at Universidade Lusófona de Humanidades e Tecnologias (ULHT), since June 2020.,Assistant Professor at ULHT (2011-2020).,Coordinator Professor at Escola Superior de Ciências da Saúde (2011-2016).,Assistant at ULHT (2005-2010).,Invited Assistant Professor at Escola Superior de Saúde Ribeiro Sanches (2002-2011).,Monitor at Faculdade de Farmácia da Universidade de Lisboa (2001-2005).

Awards and Honors:

Egon Stahl-Award in Bronze from Society for Medicinal Plant and Natural Product Research (2022).,Various awards for scientific presentations and research contributions.

Additional Skills and Activities:

  • Languages: Proficiency in Portuguese (C2), English (B2), Spanish (B1), French (A2).
  • Supervision: Supervised numerous PhD and Master’s students.
  • Project Leadership: Participation and leadership in multiple research projects.

Publications:

  • Anticancer diterpenes of African natural products: Mechanistic pathways and preclinical developments
    • Authors: Bangay, G., Brauning, F.Z., Rosatella, A., Efferth, T., Rijo, P.
    • Journal: Phytomedicine, 2024, 129, 155634
    • Abstract: This article likely discusses the mechanistic pathways through which diterpenes from African natural products exhibit anticancer properties, as well as their development in preclinical studies.
  • Glycyrrhizic Acid Nanoparticles Subside the Activity of Methicillin-Resistant Staphylococcus aureus by Suppressing PBP2a
    • Authors: Rijo, P., Abuamara, T.M.M., Ali Lashin, L.S., Abd El Maksoud, A.I., Hassan, A.
    • Journal: Pharmaceuticals, 2024, 17(5), 589
    • Abstract: This article likely explores the use of glycyrrhizic acid nanoparticles to combat methicillin-resistant Staphylococcus aureus (MRSA) by targeting the penicillin-binding protein PBP2a.
  • Halimane Derivatives from Plectranthus ornatus Codd. as Novel Anti-cancer Agents
    • Authors: Bangay, G., Brauning, F.Z., Kowalczyk, T., Sitarek, P., Rijo, P.
    • Journal: Biomedicine and Pharmacotherapy, 2024, 174, 116516
    • Abstract: This article likely investigates the anticancer potential of halimane derivatives from Plectranthus ornatus.
  • Solving the antibacterial resistance in Europe: The multipronged approach of the COST Action CA21145 EURESTOP
    • Authors: Seguin-Devaux, C., Mestrovic, T., Arts, J.J., Rijo, P., Mori, M.
    • Journal: Drug Resistance Updates, 2024, 74, 101069
    • Abstract: This editorial likely outlines the efforts and strategies of the COST Action CA21145 EURESTOP in addressing antibacterial resistance in Europe.
  • Biological Activity of 6,7-Dehydroxyroyleanone and Derivatives Obtained from Plectranthus aliciae (Codd) A.J.Paton
    • Authors: Filipe, M.S., Domínguez-Martín, E.M., Pires, T.C.S.P., Barros, L., Rijo, P.
    • Journal: ACS Omega, 2024, 9(16), pp. 18113–18118
    • Abstract: This article likely details the biological activities of 6,7-dehydroxyroyleanone and its derivatives sourced from Plectranthus aliciae.
  • Exploring the Anticancer Potential of Semisynthetic Derivatives of 7α-Acetoxy-6β-hydroxyroyleanone from Plectranthus sp.: An In Silico Approach
    • Authors: Merecz-Sadowska, A., Isca, V.M.S., Sitarek, P., Rijo, P., Zajdel, R.
    • Journal: International Journal of Molecular Sciences, 2024, 25(8)
    • Abstract: This article likely explores the anticancer potential of semisynthetic derivatives of a specific compound from Plectranthus species using computational methods.
  • Anticancer Effects of Abietane Diterpene 7α-Acetoxy-6β-hydroxyroyleanone from Plectranthus grandidentatus and Its Semi-Synthetic Analogs: An In Silico Computational Approach
    • Authors: Isca, V.M.S., Sitarek, P., Merecz-Sadowska, A., Rijo, P., Kowalczyk, T.
    • Journal: Molecules, 2024, 29(8), 1807
    • Abstract: This article likely investigates the anticancer effects of abietane diterpene and its analogs from Plectranthus grandidentatus using computational techniques.
  • Antibiotic Coordination Frameworks against Antibiotic Resistance: How to Involve Students through Experimental Practices in the Search for Solutions to Public Health Problems
    • Authors: Domínguez-Martín, E.M., Ntungwe, E., Isca, V.M.S., André, V., Rijo, P.
    • Journal: Journal of Chemical Education, 2024, 101(5), pp. 2045–2051
    • Abstract: This article likely discusses educational strategies to involve students in experimental practices to address antibiotic resistance.
  • The Precious Potential of the Sacred Tree Chamaecyparis obtusa (Siebold & Zucc.) Endl. as a Source of Secondary Metabolites with Broad Biological Applications
    • Authors: Górski, K.M., Kowalczyk, T., Picot, L., Ghorbanpour, M., Sitarek, P.
    • Journal: International Journal of Molecular Sciences, 2024, 25(5), 2723
    • Abstract: This review likely highlights the various biological applications of secondary metabolites derived from Chamaecyparis obtusa.
  • Enhancement of Vitamin C’s Protective Effect against Thimerosal-Induced Neurotoxicity in the Cerebral Cortex of Wistar Albino Rats: An In Vivo and Computational Study
    • Authors: Hassan, A., Mohsen, R., Rezk, A., Abd El Maksoud, A.I., Mohamed, A.F.
    • Journal: ACS Omega, 2024, 9(8), pp. 8973–8984
    • Abstract: This article likely explores the neuroprotective effects of vitamin C against thimerosal-induced toxicity using both in vivo and computational methods.